ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $286,163 | -9.4% | 142,349 | -8.5% | 0.00% | – |
Q2 2023 | $315,939 | +2.0% | 155,635 | 0.0% | 0.00% | – |
Q1 2023 | $309,713 | +84290.5% | 155,635 | 0.0% | 0.00% | – |
Q4 2022 | $367 | -99.9% | 155,635 | -0.2% | 0.00% | – |
Q3 2022 | $321,000 | +25.4% | 155,870 | +51.5% | 0.00% | – |
Q2 2022 | $256,000 | +15.8% | 102,911 | +6.8% | 0.00% | – |
Q1 2022 | $221,000 | +7.8% | 96,326 | +1.0% | 0.00% | – |
Q4 2021 | $205,000 | -27.3% | 95,358 | 0.0% | 0.00% | – |
Q3 2021 | $282,000 | -7.5% | 95,358 | +8.8% | 0.00% | – |
Q2 2021 | $305,000 | +5.9% | 87,659 | +10.7% | 0.00% | – |
Q1 2021 | $288,000 | +119.8% | 79,151 | +141.7% | 0.00% | – |
Q4 2020 | $131,000 | – | 32,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SG3 Management, LLC | 100,000 | $249,000 | 0.03% |
Murchinson Ltd. | 50,593 | $126,000 | 0.02% |
Marquette Asset Management, LLC | 17,318 | $43,000 | 0.01% |
SG3 Management, LLC | 22,706 | $57,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $117,000 | 0.00% |
Tekla Capital Management LLC | 32,461 | $81,000 | 0.00% |
BAILARD, INC. | 35,000 | $87,000 | 0.00% |
GROUP ONE TRADING, L.P. | 131,501 | $327,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 10,238 | $25,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 882,900 | $2,198,000 | 0.00% |